Nvelop Therapeutics, a biotechnology company engineering programmable, non-viral vehicles for the in vivo delivery of ...

Multiple Posters Highlight the Breadth of Company’s Novel Genetic Medicine and Cell Therapy PlatformsLONDON and NEW YORK, Oct. 22, 2024 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a ...

Presenter: Joseph Cabral, Ph.D. Production of AnelloVector™ therapeutics is enabled by Ring's Self-Amplifying ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

at the European Society of Gene and Cell Therapy (ESGCT) 31 st Annual Meeting taking place October 22–25, 2024, in Rome, Italy. “Our presence at ESCGT this year demonstrates our commitment to ...

at the European Society of Gene and Cell Therapy (ESGCT) 31st Annual Meeting taking place October 22–25, 2024, in Rome, Italy. “Our presence at ESCGT this year demonstrates our commitment to ...

gene therapy preclinical research programs in a poster session at the European Society of Gene and Cell Therapy (ESGCT) 31 st Annual Congress, being held October 22-25, 2024, in Rome, Italy.

Established in 1992, the European Society of Gene and Cell Therapy (ESGCT) seeks to support scientists and clinicians working in the fields of gene and cell therapy and to promote awareness and ...

Posters feature innovative technologies that address limitations of gene therapy production LAUSANNE, SWITZERLAND, October 17, 2024 ...